PPT-Oral Hypoglycemic agent
Author : jainy | Published Date : 2022-06-07
Treatment of T2DM AAmouzegar MD Endocrine Research Center Research Institute for Endocrine sciences 12298 Agenda Review ADA guideline Case presentations Conclusion
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Oral Hypoglycemic agent" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Oral Hypoglycemic agent: Transcript
Treatment of T2DM AAmouzegar MD Endocrine Research Center Research Institute for Endocrine sciences 12298 Agenda Review ADA guideline Case presentations Conclusion PatientCentric Focus of 2016 . 1098200164. Kelly Sung. Reasons. I would like to pursue a future career and determine what the obstacles are that I will need to conquer in order to become a successful DJ agent. introduction. The name “ DJ” was coined on August 13, 1941 . Outline. Agent review. Approaches to building applications. Agent & . interagent. programming tips. Incremental system development & evaluation. Summary. 1. /20. What is an Agent?. Mobile Agents. AFFIDAVIT1 NAME LAST FIRST MIDDLE2 DATE OF BIRTH4 AGENTS CURRENT CANNABIS LICENSE NUMBER eg 281282 2837 GIVEN SURNAME/BIRTH NAME if di erent from above 13 SOCIAL SECURITY NOIM INTRODUCTION. Cancer is defined as the uncontrollable growth of cells that invade and cause damage to surrounding tissue. Oral cancer appears as a growth or sore in the mouth that does not go away. Oral cancer, which includes cancers of the lips, tongue, cheeks, floor of the mouth, hard and soft palate, sinuses, and pharynx (throat), can be life threatening if not diagnosed and treated early.. By Dr Motamed. Fellow of Endocrinology and Metabolism. Endocrine Research Center. 1. 10 January 2012. Pathophysiology of Type 2 Diabetes. Peripheral Tissues. (Muscle). Glucose. Liver. Impaired insulin secretion. Case Presentation. . Discussion. Conclusions. Approach to Non-Diabetic Hypoglycemia. 2. References. Hypoglycemia. . : . glucose less than 70mg/dL. . Common hypoglycemia symptoms:. Sweating, tremors, and tachycardia. Assist. . Lec. . sura. . abbas. Type 2 DM. It is commonly associated with obesity, physical inactivity,. raised blood pressure, . dyslipidaemia. and a tendency to. develop thrombosis; therefore it increases cardiovascular. Diabetes Mellitus . Summary of Drugs Used in the Treatment of Diabetes. Diabetes Treatment . A person with . type 1 diabetes . must rely on . exogenous insulin . to . control hyperglycemia. , . avoid . Episodic sever Hypoglycemia . High level of insulin in hypoglycemic episode. High level of c-peptide . in hypoglycemic . episode. long periods without . hypoglycemia. relapse . after event-free periods of . Oral osarcoma Med Oral Patol Oral Cir Bucal 2 Oral osarcoma Oral osarcoma Med Oral Patol Oral Cir Bucal 2 Oral osarcoma Primary lei Journal section: Oral Medicine and PathologyPublication Types: Review The reappearance of a forgotten disease in the oral cavity: SyphilisHelena Viñals-Iglesias , Eduardo Chimenos-Küstner Associate – Adverse Drug Events (ADE) Iypoglycemic Agents Background • The Institute of medicine (IOM) estimates that 1.5 million preventable Adverse Drug Events (ADE) occur each year. i • On average, e The human body is designed to ensure that BG is maintained at a steady level as the energy source required for its function. Despite this, the BG level may be found to be lower than usual due to some cause. As a rule, when the body tries to elevate BG when it falls below 70 mg/. Assist . Prof . Karima F. Ali. AL-Mustansiriyah university. College of pharmacy. Pharmaceutical chemistry . Antibacterial Antibiotics. Antibacterial sulfonamides. The . sulfonamide antimicrobial drugs were the first .
Download Document
Here is the link to download the presentation.
"Oral Hypoglycemic agent"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents